Endocardial to expand with $12.7 million finance:
This article was originally published in Clinica
Endocardial Solutions has closed a $12.7 million private placement to institutional investors. The St Paul, Minnesota-based company, which develops and manufactures technology for mapping complex arrhythmias, will use the funds to "move full speed on several fronts". These include US market expansion, clinical trials for atrial fibrillation, and software and hardware product development to further enhance the Ensite 3000 system's mapping and navigational technology.